Nishikawa, G.; Kawada, K.; Hanada, K.; Maekawa, H.; Itatani, Y.; Miyoshi, H.; Taketo, M.M.; Obama, K.
Targeting Asparagine Synthetase in Tumorgenicity Using Patient-Derived Tumor-Initiating Cells. Cells 2022, 11, 3273.
https://doi.org/10.3390/cells11203273
AMA Style
Nishikawa G, Kawada K, Hanada K, Maekawa H, Itatani Y, Miyoshi H, Taketo MM, Obama K.
Targeting Asparagine Synthetase in Tumorgenicity Using Patient-Derived Tumor-Initiating Cells. Cells. 2022; 11(20):3273.
https://doi.org/10.3390/cells11203273
Chicago/Turabian Style
Nishikawa, Gen, Kenji Kawada, Keita Hanada, Hisatsugu Maekawa, Yoshiro Itatani, Hiroyuki Miyoshi, Makoto Mark Taketo, and Kazutaka Obama.
2022. "Targeting Asparagine Synthetase in Tumorgenicity Using Patient-Derived Tumor-Initiating Cells" Cells 11, no. 20: 3273.
https://doi.org/10.3390/cells11203273
APA Style
Nishikawa, G., Kawada, K., Hanada, K., Maekawa, H., Itatani, Y., Miyoshi, H., Taketo, M. M., & Obama, K.
(2022). Targeting Asparagine Synthetase in Tumorgenicity Using Patient-Derived Tumor-Initiating Cells. Cells, 11(20), 3273.
https://doi.org/10.3390/cells11203273